Language：English   Publishing type：Research paper (scientific journal)  

BACKGROUND: Plasminogen serves as the precursor to plasmin, an essential element in the fibrinolytic process, and is synthesized primarily in the liver. Plasminogen activation occurs through the action of plasminogen activator, converting it into plasmin. This conversion greatly enhances the fibrinolytic system within tissues and blood vessels, facilitating the dissolution of fibrin clots. Consequently, congenital deficiency of plasminogen results in impaired fibrin degradation. Patients with plasminogen deficiency typically exhibit fibrin deposits in various mucosal sites throughout the body, including the oral cavity, eyes, vagina, and digestive organs. Behcet's disease is a chronic recurrent systemic inflammatory disease with four main symptoms: aphthous ulcers of the oral mucosa, vulvar ulcers, skin symptoms, and eye symptoms, and has been reported worldwide. This disease is highly prevalent around the Silk Road from the Mediterranean to East Asia. We report a case of periodontitis in a patient with these two rare diseases that worsened quickly, leading to alveolar bone destruction. Genetic testing revealed a novel variant characterized by a stop-gain mutation, which may be a previously unidentified etiologic gene associated with decreased plasminogen activity. CASE PRESENTATION: This case report depicts a patient diagnosed with ligneous gingivitis during childhood, originating from plasminogen deficiency and progressing to periodontitis. Genetic testing revealed a suspected association with the PLG c.1468C > T (p.Arg490*) stop-gain mutation. The patient's periodontal condition remained stable with brief intervals of supportive periodontal therapy. However, the emergence of Behçet's disease induced acute systemic inflammation, necessitating hospitalization and treatment with steroids. During hospitalization, the dental approach focused on maintaining oral hygiene and alleviating contact-related pain. The patient's overall health improved with inpatient care and the periodontal tissues deteriorated. CONCLUSIONS: Collaborative efforts between medical and dental professionals are paramount in comprehensively evaluating and treating patients with intricate complications from rare diseases. Furthermore, the PLG c.1468C > T (p.Arg490*) stop-gain mutation could contribute to the association between plasminogen deficiency and related conditions.

DOI： 10.1186/s12903-023-03586-8

PubMed

researchmap

Authorship：Corresponding author   Language：English   Publishing type：Research paper (scientific journal)  

Dental caries are an oral infectious disease that can affect human health both orally and systemically. It remains an urgent issue to establish a novel antibacterial method to prevent oral infection for a healthy life expectancy. The aim of this study was to evaluate the inhibitory effects of novel iron chelators, super-polyphenols (SPs), on the cariogenic bacterium Streptococcus mutans, in vitro. SPs were developed to reduce the side effects of iron chelation therapy and were either water-soluble or insoluble depending on their isoforms. We found that SP6 and SP10 inhibited bacterial growth equivalent to povidone-iodine, and viability tests indicated that their effects were bacteriostatic. These results suggest that SP6 and SP10 have the potential to control oral bacterial infections such as Streptococcus mutans.

DOI： 10.3390/antibiotics12111562

PubMed

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

重度の歯周炎症が糖尿病の病態に悪影響を及ぼすことは知られている。今回,急激な血糖値(HbA1c)悪化の背景に,重度歯周炎症の関与を疑った症例を報告する。患者は78歳,男性。2021年3月,血糖値の急激な悪化(HbA1c=13.8%)をかかりつけ内科で指摘され,大学病院糖尿病内科に教育入院した。同科で歯周病検査の必要性を指摘され,同院歯科(歯周科部門)へ紹介された。同歯科での検査において,重度の歯周炎の進行を指摘され,専門的な歯周治療介入が早期に必要と判断された。歯周病専門医のいる当院での加療を希望し,2021年5月に受診した。歯周組織検査において,4mm以上のPPDの割合は76%,BOP陽性率は81%,PCRは100%,PISAは3,217mm2であった。エックス線検査所見では,全顎的に中等度の水平性骨吸収の進行を確認し,37,47には根尖におよぶ骨吸収像が存在した。診断は,広汎型重度慢性歯周炎(ステージIV,グレードC)とした。糖尿病の病態への影響を考慮しながら,局所抗菌薬併用SRPを主体とした歯周基本治療を行った。歯周治療に対する反応性は非常に良く,歯周炎症の改善(再評価時のPISA:605mm2)とともに,HbA1c値は6.5%に改善した(2022年1月)。緊密な医科歯科連携によって,早期に専門的歯周治療介入を行えたことが良好な血糖値の改善につながったと考える。(著者抄録)

researchmap

Authorship：Lead author   Language：Japanese   Publisher：(一社)日本成人先天性心疾患学会  

歯科治療は,観血的処置にはみえなくても菌血症を起こすリスクが高い.今回,感染性心内膜炎(IE)高リスクに分類されるフォンタン手術後の患者が歯科治療に起因すると考えられる感染症を起こし,緊急入院に至る症例を経験した.患者は20歳の男性.多脾症候群,右室型単心室に対して,両側両方向性グレン手術とフォンタン手術の手術歴がある.2021年6月,近医で下顎左側第二大臼歯(#37)の慢性根尖性歯周炎の診断のもと,予防的抗菌薬の投与なく歯内治療を開始した.2021年7月,治療中の#37部の自発痛,悪寒,戦慄,発熱を自覚し,当院循環器内科を緊急受診した.履歴から歯性感染が疑われたため,当院歯周科へ緊急紹介され,#37急性根尖性歯周炎と診断した.IE高リスク患者のため緊急入院となり,経験的抗菌療法を開始した.入院5日目,抗菌薬持続投与下で#37の歯内治療を再開,入院12日目に歯内治療を終了,入院13日目に退院した.今回の症例を教訓に,患者自身が歯科治療に先立ち予防的抗菌薬投与の必要性を簡便に提示できる患者カードを作成した.本カードが適切に運用され,歯科治療由来のIE発症リスクが軽減されることを期待する.(著者抄録)

researchmap

Publishing type：Research paper (scientific journal)   Publisher：MDPI AG  

Apical periodontitis is an inflammatory response caused by pulp infection. It induces bone resorption in the apical and periapical regions of the tooth. The most conservative approach to treat this condition is nonsurgical endodontic treatment. However, clinical failure has been reported with this approach; thus, alternative procedures are required. This review highlights recent literature regarding advanced approaches for the treatment of apical periodontitis. Various therapies, including biological medications, antioxidants, specialized pro-resolving lipid mediators, and stem cell therapy, have been tested to increase the success rate of treatment for apical periodontitis. Some of these approaches remain in the in vivo phase of research, while others have just entered the translational research phase to validate clinical application. However, a detailed understanding of the molecular mechanisms that occur during development of the immunoinflammatory reaction in apical periodontitis remains unclear. The aim of this review was to summarize advanced approaches for the treatment of apical periodontitis. Further research can confirm the potential of these alternative nonsurgical endodontic treatment approaches.

DOI： 10.3390/bioengineering10040488

researchmap

Authorship：Corresponding author   Publishing type：Research paper (scientific journal)   Publisher：MDPI AG  

Current periodontal treatment focuses on the mechanical removal of the source of infection, such as bacteria and their products, and there is no approach to control the host inflammatory response that leads to tissue destruction. In order to control periodontal inflammation, we have previously reported the optimization of (+)-terrein synthesis methods and the inhibitory effect of (+)-terrein on osteoclast differentiation in vitro. However, the pharmacological effect of (+)-terrein in vivo in the periodontitis model is still unknown. In this study, we investigated the effect of synthetic (+)-terrein on inflammatory bone resorption using a ligature-induced periodontitis mouse model. Synthetic (+)-terrein (30 mg/kg) was administered intraperitoneally twice a week to the mouse periodontitis model. The control group was treated with phosphate buffer. One to two weeks after the induction of periodontitis, the periodontal tissues were harvested for radiological evaluation (micro-CT), histological evaluation (HE staining and TRAP staining), and the evaluation of inflammatory cytokine production in the periodontal tissues and serum (quantitative reverse-transcription PCR, ELISA). The synthetic (+)-terrein-treated group suppressed alveolar bone resorption and the number of osteoclasts in the periodontal tissues compared to the control group (p < 0.05). In addition, synthetic (+)-terrein significantly suppressed both mRNA expression of TNF-α in the periodontal tissues and the serum concentration of TNF-α (both p < 0.05). In conclusion, we have demonstrated that synthetic (+)-terrein abrogates alveolar bone resorption via the suppression of TNF-α production and osteoclast differentiation in vivo. Therefore, we could expect potential clinical effects when using (+)-terrein on inflammatory bone resorption, including periodontitis.

DOI： 10.3390/jof9030314

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

The major active form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25D3), is known for its wide bioactivity in periodontal tissues. Although the exact mechanisms underlying its protective action against periodontitis remain unclear, recent studies have shown that 1,25D3 regulates autophagy. Autophagy is vital for intracellular pathogen invasion control, inflammation regulation, and bone metabolic balance in periodontal tissue homeostasis, and its regulation could be an interesting pathway for future periodontal studies. Since vitamin D deficiency is a worldwide health problem, its role as a potential regulator of autophagy provides new insights into periodontal diseases. Based on this premise, this narrative literature review aimed to investigate the possible connection between 1,25D3 and autophagy in periodontitis. A comprehensive literature search was conducted on PubMed using the following keywords (e.g., vitamin D, autophagy, periodontitis, pathogens, epithelial cells, immunity, inflammation, and bone loss). In this review, the latest studies on the protective action of 1,25D3 against periodontitis and the regulation of autophagy by 1,25D3 are summarized, and the potential role of 1,25D3-activated autophagy in the pathogenesis of periodontitis is analyzed. 1,25D3 can exert a protective effect against periodontitis through different signaling pathways in the pathogenesis of periodontitis, and at least part of this regulatory effect is achieved through the activation of the autophagic response. This review will help clarify the relationship between 1,25D3 and autophagy in the homeostasis of periodontal tissues and provide perspectives for researchers to optimize prevention and treatment strategies in the future.

DOI： 10.1186/s12903-023-02802-9

PubMed

researchmap

DOI： 10.34376/jsachd.C-2022-0002

researchmap

Publishing type：Research paper (scientific journal)   Publisher：Tokyo Dental College  

DOI： 10.2209/tdcpublication.2022-0019

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

The study aims to reveal the composition of subgingival bacteria in monozygotic twins with discordant in severity and progression risk of periodontitis. Microbiome analysis indicated that most bacteria were heritable but differed in their abundance and immune response. The dysbiotic bacteria can be considered as risk markers for periodontitis progression.

DOI： 10.1002/ccr3.5725

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Porphyromonas gingivalis is commonly known as one of the major pathogens contributing to periodontitis, and its persistent infection may increase the risk for the disease. The proinflammatory mediators, including IL-6, TNF-α, and cyclooxygenase-2 (COX-2)/PGE2, are closely associated with progression of periodontitis. In this study, we focused on the cysteine protease "gingipains," lysine-specific gingipain, arginine-specific gingipain (Rgp) A, and RgpB, produced by P. gingivalis, and used the wild-type strain and several gene-deletion mutants (rgpA, rgpB, kgp, and fimA) to elucidate the involvement of gingipains in COX-2 expression and PGE2 production. We infected human monocytes, which are THP-1 cells and primary monocytes, with these bacterial strains and found that gingipains were involved in induction of COX-2 expression and PGE2 production. We have shown that the protease activity of gingipains was crucial for these events by using gingipain inhibitors. Furthermore, activation of ERK1/2 and IκB kinase was required for gingipain-induced COX-2 expression/PGE2 production, and these kinases activated two transcription factors, c-Jun/c-Fos (AP-1) and NF-κB p65, respectively. In particular, these data suggest that gingipain-induced c-Fos expression via ERK is essential for AP-1 formation with c-Jun, and activation of AP-1 and NF-κB p65 plays a central role in COX-2 expression/PGE2 production. Thus, we show the (to our knowledge) novel finding that gingipains with the protease activity from P. gingivalis induce COX-2 expression and PGE2 production via activation of MEK/ERK/AP-1 and IκB kinase/NF-κB p65 in human monocytes. Hence it is likely that gingipains closely contribute to the inflammation of periodontal tissues.

DOI： 10.4049/jimmunol.2100866

PubMed

researchmap

Authorship：Corresponding author   Language：English   Publishing type：Research paper (scientific journal)   Publisher：Frontiers Media SA  

Osteoporosis is a common disease characterized by a systemic impairment of bone mass and microarchitecture that results in fragility fractures. Severe bone loss due to osteoporosis triggers pathological fractures and consequently decreases the daily life activity and quality of life. Therefore, prevention of osteoporosis has become an important issue to be addressed. We have reported that the fungal secondary metabolite (+)-terrein (TER), a natural compound derived from <italic>Aspergillus terreus</italic>, has shown receptor activator of nuclear factor-κB ligand (RANKL)–induced osteoclast differentiation by suppressing nuclear factor of activated T-cell 1 (NFATc1) expression, a master regulator of osteoclastogenesis. TER has been shown to possess extensive biological and pharmacological benefits; however, its effects on bone metabolism remain unclear. In this study, we investigated the effects of TER on the femoral bone metabolism using a mouse-ovariectomized osteoporosis model (OVX mice) and then on RANKL signal transduction using mouse bone marrow macrophages (mBMMs). <italic>In vivo</italic> administration of TER significantly improved bone density, bone mass, and trabecular number in OVX mice (<italic>p</italic> &amp;lt; 0.01). In addition, TER suppressed TRAP and cathepsin-K expression in the tissue sections of OVX mice (<italic>p</italic> &amp;lt; 0.01). In an <italic>in vitro</italic> study, TER suppressed RANKL-induced phosphorylation of PKCα/βII, which is involved in the expression of NFATc1 (<italic>p</italic> &amp;lt; 0.05). The PKC inhibitor, GF109203X, also inhibited RANKL-induced osteoclastogenesis in mBMMs as well as TER. In addition, TER suppressed the expression of osteoclastogenesis-related genes, such as <italic>Ocstamp</italic>, <italic>Dcstamp</italic>, <italic>Calcr</italic>, <italic>Atp6v0d2</italic>, <italic>Oscar</italic>, and <italic>Itgb3</italic> (<italic>p</italic> &amp;lt; 0.01). These results provide promising evidence for the potential therapeutic application of TER as a novel treatment compound against osteoporosis.

DOI： 10.3389/fphar.2021.674366

researchmap

Authorship：Lead author   Language：Japanese   Publisher：(NPO)日本歯科保存学会  

緒言:歯周病原細菌の感染と歯周組織の炎症が,妊娠に影響を与える可能性が報告されている.今回,不妊治療の経過が思わしくない侵襲性歯周炎患者に感染源除去の観点から専門的歯周治療を行い,自然妊娠から正常出産にいたった症例の経過をふまえ病態を考察する.症例:33歳,女性,既婚(不妊治療中).2016年9月,26の動揺および同部の自発痛を自覚し,かかりつけ歯科医院を受診した.同院でエックス線検査を受けて,重度の歯槽骨吸収があると説明された.早期の専門的歯周治療を勧められ,当科を紹介された.既往歴の特記事項はなく,不妊検査においても患者本人および夫ともに異常所見はなかった.歯周組織検査において,probing pocket depthが4mm以上の部位の割合は49.5%,bleeding on probingは47.9%,plaque control recordは3.1%,歯周炎症表面積(PISA)は2,392mm2であった.エックス線検査所見では,主訴部の26部を中心に根尖に及ぶ骨吸収像が多数存在した.歯周病原細菌に対する血清抗体価検査および歯周ポケット内細菌DNA検査ともに,Porphyromonas gingivalisの感染が強く疑われた.診断は広汎型侵襲性歯周炎(ステージIV,グレードC),二次性咬合性外傷とした.治療方針として,患者の妊娠希望に配慮して,できるかぎり早期(1年以内)の歯周環境の改善を目指すこととした.また,歯周外科治療が終了するまでの不妊治療を含めた妊娠活動を控える必要性について説明し,同意を得た.治療計画は,(1)歯周基本治療(患者教育,抜歯,局所抗菌療法を併用したスケーリング・ルートプレーニング,暫間固定),(2)歯周組織再生療法,(3)口腔機能回復治療,(4)歯周病安定期治療(SPT)とした.治療経過として,歯周治療に対する宿主反応性は非常に良く,炎症改善と歯槽骨の再生を確認した(歯周外科治療後PISA:43mm2).口腔機能回復治療中に自然妊娠し,35歳時に男児を正常出産(経腟分娩,3,240g,出産週数:38週+5日)した.考察および結論:重度のP. gingivalis感染および歯周炎症を伴う侵襲性歯周炎の罹患が,妊娠成立に影響を及ぼす可能性が示唆された.本症例のように不妊治療の経過が思わしくない場合には,歯周組織を含めた口腔状態を一度精査することが望まれる.(著者抄録)

researchmap

Other Link： https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2020&ichushi_jid=J01092&link_issn=&doc_id=20201110310013&doc_link_id=%2Fdo1conde%2F2020%2F006305%2F013%2F0451-0460%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fdo1conde%2F2020%2F006305%2F013%2F0451-0460%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

Authorship：Corresponding author   Language：English   Publishing type：Research paper (scientific journal)  

Pathophysiological bone resorption is commonly associated with periodontal disease and involves the excessive resorption of bone matrix by activated osteoclasts. Receptor activator of nuclear factor (NF)-κB ligand (RANKL) signaling pathways have been proposed as targets for inhibiting osteoclast differentiation and bone resorption. The fungal secondary metabolite (+)-terrein is a natural compound derived from Aspergillus terreus that has previously shown anti-interleukin-6 properties related to inflammatory bone resorption. However, its effects and molecular mechanism of action on osteoclastogenesis and bone resorption remain unclear. In the present study, we showed that 10 µM synthetic (+)-terrein inhibited RANKL-induced osteoclast formation and bone resorption in a dose-dependent manner and without cytotoxicity. RANKL-induced messenger RNA expression of osteoclast-specific markers including nuclear factor of activated T-cells cytoplasmic 1 (NFATc1), the master regulator of osteoclastogenesis, cathepsin K, tartrate-resistant acid phosphatase (Trap) was completely inhibited by synthetic (+)-terrein treatment. Furthermore, synthetic (+)-terrein decreased RANKL-induced NFATc1 protein expression. This study revealed that synthetic (+)-terrein attenuated osteoclast formation and bone resorption by mediating RANKL signaling pathways, especially NFATc1, and indicated the potential effect of (+)-terrein on inflammatory bone resorption including periodontal disease.

DOI： 10.1016/j.intimp.2020.106429

PubMed

researchmap

Publishing type：Research paper (scientific journal)  

© 2019, The Society of The Nippon Dental University. Dental caries is a type of oral microbiome dysbiosis and biofilm infection that affects oral and systemic conditions. For healthy life expectancy, natural bacteriostatic products are ideal for daily and lifetime use as anti-oral infection agents. This study aimed to evaluate the inhibitory effects of abietic acid, a diterpene derived from pine rosin, on the in vitro growth of cariogenic bacterial species, Streptococcus mutans. The effective minimum inhibitory concentration of abietic acid was determined through observation of S. mutans growth, acidification, and biofilm formation. The inhibitory effects of abietic acid on the bacterial membrane were investigated through the use of in situ viability analysis and scanning electron microscopic analysis. Cytotoxicity of abietic acid was also examined in the context of several human cell lines using tetrazolium reduction assay. Abietic acid was found to inhibit key bacterial growth hallmarks such as colony forming ability, adenosine triphosphate activity (both planktonic and biofilm), acid production, and biofilm formation. Abietic acid was identified as bacteriostatic, and this compound caused minimal damage to the bacterial membrane. This action was different from that of povidone-iodine or cetylpyridinium chloride. Additionally, abietic acid was significantly less cytotoxic compared to povidone-iodine, and it exerted lower toxicity towards epithelial cells and fibroblasts compared to that against monocytic cells. These data suggest that abietic acid may prove useful as an antibacterial and antibiofilm agent for controlling S. mutans infection.

DOI： 10.1007/s10266-019-00456-0

Scopus

PubMed

researchmap

Publishing type：Research paper (scientific journal)  

© 2020, The Society of The Nippon Dental University. There is no conclusive evidence regarding a causal relationship between periodontitis and atherosclerosis. In this study, we examined the microbiome in the oral cavity and atheromatous plaques from atherosclerosis patients with or without periodontitis to investigate the role of oral bacteria in the formation of atheromatous plaques. We chose four patients with and without periodontitis, who had undergone carotid endarterectomy. Bacterial samples were extracted from the tongue surface, from periodontal pocket (during the oral examination), and from the atheromatous plaques (APs). We investigated the general and oral conditions from each patient and performed next-generation sequencing (NGS) analysis for all bacterial samples. There were no significant differences between both groups concerning general conditions. However, the microbiome patterns of the gingival pocket showed differences depending on the absence or presence of periodontitis, while those of the tongue surface were relatively similar. The microbiome pattern of the atheromatous plaques was entirely different from that on the tongue surface and gingival pocket, and oral bacteria were seldom detected. However, the microbiome pattern in atheromatous plaques was different in the presence or absence of periodontitis. These results suggested that oral bacteria did not affect the formation of atheromatous plaques directly.

DOI： 10.1007/s10266-020-00524-w

Scopus

researchmap

Publishing type：Research paper (scientific journal)  

© 2019 The Authors. Journal of Periodontology published by Wiley Periodicals, Inc. on behalf of American Academy of Periodontology Background: Basic fibroblast growth factor (bFGF) has been applied for periodontal regeneration. However, the application depends on bone defect morphology because bFGF diffuses rapidly from defect sites. In a previous study, collagen-binding bFGF (CB-bFGF) has been shown to enhance bone formation by collagen-anchoring in the orthopedic field. The aim of this study is to demonstrate the efficacy of CB-bFGF with collagen scaffolds in bone regeneration of horizontal bone defect. Methods: Cell proliferation activity and collagen binding activity of CB-bFGF was confirmed by WST-8 assay and collagen binding assay, respectively. The retention of CB-bFGF in the collagen sheet (CS) was measured by fluorescence imaging. The rat horizontal alveolar bone defect model was employed to investigate the efficacy of CB-bFGF with collagen powder (CP). After 4 and 8 weeks, the regenerative efficacy was evaluated by microcomputed tomography, histological, and immunohistochemical analyses. Results: CB-bFGF had a comparable proliferation activity to bFGF and a collagen binding activity. CB-bFGF was retained in CS longer than bFGF. At 8 weeks postoperation, bone volume, bone mineral content, and new bone area in CB-bFGF/CP group were significantly increased compared with those in other groups. Furthermore, epithelial downgrowth was significantly suppressed in CB-bFGF/CP group. At 4 weeks, the numbers of osteocalcin, proliferating cell nuclear antigen, and osteopontin-positive cells at the regeneration site in CB-bFGF/CP group were greater than those in other groups. Conclusions: CB-bFGF/CP effectively promoted bone regeneration of horizontal bone defect possibly by sustained release of bFGF. The potential of CB-bFGF composite material for improved periodontal regeneration in vertical axis was shown.

DOI： 10.1002/JPER.18-0674

Scopus

PubMed

researchmap

Publishing type：Research paper (scientific journal)   Publisher：Frontiers Media SA  

DOI： 10.3389/fimmu.2019.00307

PubMed

researchmap

Publishing type：Research paper (scientific journal)  

© 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. The recruitment of tissue-resident stem cells is important for wound regeneration. Periodontal ligament cells (PDL cells) are heterogeneous cell populations with stemness features that migrate into wound sites to regenerate periodontal fibres and neighbouring hard tissues. Cell migration is regulated by the local microenvironment, coordinated by growth factors and the extracellular matrix (ECM). Integrin-mediated cell adhesion to the ECM provides essential signals for migration. We hypothesized that PDL cell migration could be enhanced by selective expression of integrins. The migration of primary cultured PDL cells was induced by platelet-derived growth factor-BB (PDGF-BB). The effects of blocking specific integrins on migration and ECM adhesion were investigated based on the integrin expression profiles observed during migration. Up-regulation of integrins α3, α5, and fibronectin was identified at distinct localizations in migrating PDL cells. Treatment with anti-integrin α5 antibodies inhibited PDL cell migration. Treatment with anti-integrin α3, α3-blocking peptide, and α3 siRNA significantly enhanced cell migration, comparable to treatment with PDGF-BB. Furthermore, integrin α3 inhibition preferentially enhanced adhesion to fibronectin via integrin α5. These findings indicate that PDL cell migration is reciprocally regulated by integrin α3-mediated inhibition and α5-mediated promotion. Thus, targeting integrin expression is a possible therapeutic strategy for periodontal regeneration.

DOI： 10.1111/jcmm.14023

Scopus

PubMed

researchmap

Authorship：Corresponding author   Language：English   Publishing type：Research paper (scientific journal)  

Control of bacterial infection-induced inflammatory responses is one of the effective therapeutic approaches of periodontal diseases. Natural products such as lipid mediators and metabolites from microorganisms have been used for decreasing inflammation. We previously reported that (+)-terrein inhibited activation of STAT3 and ERK1/2 in interleukin-6 (IL-6) signaling cascade, leading to prevent vascular endothelial growth factor (VEGF) secretion in human gingival fibroblasts (HGFs). However, little is still known about the role of (+)-terrein on inflammatory responses. In this study, we provided the possibility of novel action that (+)-terrein inhibits activation of Janus-activated kinase 1 (JAK1), which has a central function in IL-6 signaling cascade, and alters expression of mRNAs and proteins induced by IL-6/soluble IL-6 receptor (sIL-6R) stimulation in HGFs. First, we performed PCR array to examine IL-6/sIL-6R-induced mRNA expression, and then expression of mRNA and protein of colony stimulating factor-1 (CSF1) and VEGF were clearly determined by quantitative RT-PCR and ELISA, respectively. Treatment with (+)-terrein suppressed expression of mRNA and protein of CSF1 and VEGF by IL-6/sIL-6R stimulation. Next, to test the effect of (+)-terrein on IL-6/sIL-6R signaling cascade, we demonstrated whether (+)-terrein affects phosphorylation of JAK1 and its downstream proteins, Akt and SHP-2. Western blotting revealed that (+)-terrein inhibited IL-6/sIL-6R-induced phosphorylation of JAK1, Akt, and SHP-2. Therefore, (+)-terrein suppresses IL-6/sIL-6R-induced expression of CSF1 and VEGF via inhibition of JAK1, Akt, and SHP-2. Based on our results, we suggest that (+)-terrein is a candidate compound for anti-inflammatory effect associated with IL-6 signaling.

DOI： 10.1016/j.heliyon.2018.e00979

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

Iron chelation therapy is the main treatment for iron overload disease. Iron chelators were recently reported to be useful for cancer therapy; however, they cause side effects that make them difficult to use in some cancer patients. Thus, a novel oral iron chelator, super-polyphenol (SP), was developed for cancer therapy to decrease the side effects. SP is either water soluble or insoluble, and has different isoforms according to the number of side chains. Of these isoforms, water-soluble SP6 and SP10 appear to be the best candidates, as they have the strongest chelating abilities. In this study, we focused on the usefulness and safety of SP6 and SP10 as anti-cancer drugs, and examined their anti-cancer effects and toxicity. The results showed that SP6 and SP10 inhibited cancer cell proliferation by inducing apoptosis in HCT116, HSC-2, A549, and MCF-7 cancer cells. SP10 also inhibited tumor growth in an HCT116 xenograft model. SP6 and SP10 had no acute toxicities. An intravenous injection test revealed that SP6 and SP10 had better safety profiles than the iron chelator deferoxamine. In conclusion, SP is a novel oral iron chelator with anti-cancer effects and few adverse side effects. This is the first report of SP in the literature.

DOI： 10.18632/oncotarget.25973

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)  

BACKGROUND: A number of studies have suggested a bidirectional relationship of periodontitis with rheumatoid arthritis (RA) and type 2 diabetes mellitus (T2DM). However, the genetic factors that underlie these relationships have not been elucidated. METHODS: We conducted a multicenter case-control study that included 185 patients with RA and chronic periodontitis (CP), 149 patients with T2DM and CP, 251 patients with CP, and 130 systemically and periodontally healthy controls from a cohort of Japanese adults to assess the shared genetic risk factors for RA and CP as well as for T2DM and CP. A total of 17 candidate single nucleotide polymorphisms (SNPs) associated with RA, T2DM, and CP were genotyped. RESULTS: Multiple logistic regression analyses revealed that the KCNQ1 rs2237892 was significantly associated with comorbidity of RA and CP (P = 0.005) after adjustment for age, sex, and smoking status. The carriers of the T allele among patients with RA and CP showed significantly higher disease activity scores including 28 joints using C-reactive protein values than the non-carriers (P = 0.02), although the age, female percentage, and smoking status were comparable. Other SNPs were not associated with comorbidity of RA and CP, T2DM and CP, or susceptibility to CP. CONCLUSION: The results of the present pilot study suggest for the first time that the KCNQ1 rs2237892 may constitute a shared genetic risk factor for RA and CP, but not for T2DM and CP in Japanese adults.

DOI： 10.1002/JPER.17-0412

PubMed

researchmap

Language：English  

Oral bacteria cause infective endocarditis (IE), so severe periodontitis is thought to be high risk for IE. We suggest the identification of high-risk patients by an IgG antibody titer test against periodontal bacteria might become common screening test.

DOI： 10.1002/ccr3.1066

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：Luigi Ponzio e figlio Editori  

An insertion sequence, IS1598 (IsPg4) has been found in virulent strains of Porphyromonas gingivalis in a murine abscess model. The present study was performed to investigate the effects of genetic rearrangements by IS1598 on the phenotypic characteristics of the virulent strains. For this purpose, we searched for a common insertion site of IS1598 among the virulent strains. Through cloning and database search, a common insertion site was identified beside an nrdD-like gene in the virulent FDC 381, W83 and W50 strains. In this region, predicted promoters of the nrdD-like gene and IS1598 are located in tandem, and accumulation of nrdD-like gene mRNA was 5-fold higher in virulent strains (W83, W50, FDC 381) than avirulent strains (ATCC33277, SU63, SUNY1021, ESO59 without IS1598). The role of the nrdD-like gene in virulence of P. gingivalis was investigated by constructing a nrdD-deficient mutant. In the murine abscess model, the parental W83 strain produced necrotic abscesses, while the nrdD-deficient mutant had almost lost this ability. Insertion of IS1598 into the nrdD-like gene promoter region may be related to the phenotypic differences in virulence among P. gingivalis strains through upregulation of the expression of this gene.

Web of Science

Scopus

PubMed

researchmap

Language：Japanese   Publisher：(一社)日本糖尿病合併症学会  

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：INT INST ANTICANCER RESEARCH  

Background/Aim: Head and neck cancers are the fifth most common cancer type worldwide, affecting more than half a million patients annually. Development of effective therapeutic drugs is, therefore, required for this type of disease. This study assessed the effects of synthetic terrein on head and neck cancer. Materials and Methods: Synthetic terrein was prepared by using the modified Altenhach's procedure. The effect of synthetic terrein on cell proliferation of head and neck cancer cells and HUVECs was assessed. Angiogenin secretion and ribosome biogenesis were examined by ELISA and silver staining of the nucleolar organizer region. A mouse xenograft model was prepared by inoculating mice with suspensions of cells of the human head and neck cancer cell line OSC-19 subcutaneously into the dorsal region of each mouse. Ki-67, CD31 and angiogenin expression in xenografted tumors was examined by immunohistochemistry. Results: Synthetic terrein inhibited the growth of various head and neck cancer cells. In addition, an in vivo experiment revealed that synthetic terrein inhibited a xenograft tumor growth in athymic mice. Immunohistochemical analysis revealed that expression of Ki-67, CD31 and ANG was down-regulated in synthetic terrein-treated tumors, compared to controls. Synthetic terrein suppressed the ANG secretion and ribosome biogenesis in cancer cells, and cell proliferation in vascular endothelial cells. Conclusion: The mechanism underlying the anti-tumor effects of synthetic terrein against head and neck cancer consists of the inhibition of both tumor cell proliferation and angiogenesis via the suppression of ANG production.

Web of Science

PubMed

researchmap

Language：Japanese   Publisher：(株)医学書院  

researchmap

Authorship：Lead author   Language：English  

It has been suggested that vitamin C deficiency/scurvy is associated with gingival inflammatory changes; however, the disorder is very infrequently encountered in the modern era. Here, we report a case of extensive gingival overgrowth caused by vitamin C deficiency associated with metabolic syndrome and severe periodontal infection.

DOI： 10.1002/ccr3.114

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：PERGAMON-ELSEVIER SCIENCE LTD  

Interleukin (IL)-6 is a proinflammatory cytokine that performs a wide variety of biological functions, including important roles in the progression of chronic inflammatory diseases such as periodontal disease. (+)-Terrein, a secondary bioactive fungal metabolite isolated from Aspergillus terreus, has various biological activities; however, its anti-inflammatory effects are still unknown. The purpose of this study was to examine the effect of synthetic (+)-terrein on IL-6 signaling and related protein production in human gingival fibroblasts. To our knowledge, this study is the first to report that synthetic (+)-terrein is not cytotoxic at concentrations less than 20 mu M and suppresses IL-6/soluble IL-6 receptor (sIL-6R)-induced phosphorylation of signal transducer and activator of transcription-3, extracellular signal-regulated kinase 1/2, and c-jun N-terminal kinase 1/2-signaling proteins that are downstream of IL-6 signaling. In addition, synthetic (+)-terrein suppresses IL-6/sIL-6R-induced vascular endothelial growth factor (VEGF) secretion in a concentration-dependent manner (p &lt; 0.01). These data suggest that synthetic (+)-terrein has potential anti-IL-6 signaling activity and suppresses VEGF-associated inflammatory disease progression. (C) 2014 Elsevier Ltd. All rights reserved.

DOI： 10.1016/j.bmc.2014.07.047

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：WILEY-BLACKWELL  

Both group I (HSP60) and group II (CCT) chaperonins are targets of autoantibodies. Autoimmune reactions to HSP60 have been well characterized, while immune reactions to group II chaperonin have not been clarified. Methanobrevibacter oralis is a suspected periodontal pathogen with group II chaperonin. In this study, serum responses to M.oralis chaperonin, human HSP60, and CCT subunits were examined using sera from patients with periodontitis and autoimmune diseases. In comparison with healthy controls, periodontitis patients showed significantly higher responses to CCT4 and CCT8 on dot blot analysis. Signals for CCT3 and CCT8 in autoimmune disease patients were significantly higher than in controls. Significant differences were also demonstrated by Western blotting in anti-CCT4 response in both patient groups. All subjects showed strong reactivity to M.oralis chaperonin and faint signals to human HSP60. Autoantibodies were raised against CCT rather than HSP60; and CCT3, CCT4, and CCT8 were shown to be the main targets. Host immune systems may be frequently exposed to chaperonins of Archaea in various habitats. Although further studies of the cross-reactivity between M.oralis chaperonin and human CCT are required, anti-CCT autoantibodies may be involved in the pathogenesis of periodontitis and autoimmune diseases.

DOI： 10.1111/2049-632X.12041

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：BIOLIFE SAS  

Periodontitis is localized infectious disease caused by periodontopathic bacteria such as Porphyromonas gingivalis (T: gingivalis), and the severity correlates to significance of immune responses. Recently, it has been reported that periodontitis is associated with the development of systemic disease such as diabetes and atherosclerosis because of increasing invasion of oral pathogens to the circulation. However, the association between local and systemic infectious responses is still unclear. In the present study, we examined the differences of biological responses in animals with or without bacterial infection. After Balb/c mice were infected subcutaneously with live P gingivalis W83, serum, skin and liver were collected according to experimental protocol. The skin and liver tissues were observed pathologically by haematoxylin-eosin staining, and serum IL-6 levels were measured using ELISA method. Throughout the experimental period, conditions of the mice were observed continuously. As expected, severe infiltration of leukocytes were observed at inflamed skin corresponding to the number of bacterial challenges. Although no inflammatory appearance of skin was observed, serum IL-6 levels were increased dramatically (P &lt; 0.01, Student&apos;s t-test) and liver tissues were injured in the mice without bacterial challenge. Interestingly, although severe inflammatory appearance of the skin was observed, serum IL-6 levels were not increased and no inflammatory responses were observed in the liver of the 3-times bacterially challenged group. Importantly, immunoglobulin G against P gingivalis W83 was detected in the blood of mice with 3-times bacterial challenge corresponding to improvement of weight loss and survival. In conclusion, although multiple infections develop severe localized inflammation, the immune system should be sufficient to protect the systemic inflammatory responses.

Web of Science

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：AMER ASSOC IMMUNOLOGISTS  

Neutrophils from people with poorly controlled diabetes present a primed phenotype and secrete excessive superoxide. Phospholipase A(2) (PLA(2))-derived arachidonic acid (AA) activates the assembly of NADPH oxidase to generate superoxide anion. There is a gap in the current literature regarding which PLA(2) isoform regulates NADPH oxidase activation. The aim of this study was to identify the PLA(2) isoform involved in the regulation of superoxide generation in neutrophils and investigate if PLA(2) Mediates priming in response to pathologic hyperglycemia. Neutrophils were isolated from people with diabetes mellitus and healthy controls, and HL60 neutrophil-like cells were grown in hyperglycemic conditions. Incubating neutrophils with the Ca2+-independent PLA(2) (iPLA(2)) inhibitor bromoenol lactone (BEL) completely suppressed fMLP-induced generation of superoxide. The nonspecific actions of BEL on phosphatidic acid phosphohydrolase-1, p47(phox) phosphorylation, and apoptosis were ruled out by specific assays. Small interfering RNA knockdown of iPLA(2) inhibited superoxide generation by neutrophils. Neutrophils from people with poorly controlled diabetes and in vitro incubation of neutrophils with high glucose and the receptor for advanced glycation end products ligand S100B greatly enhanced superoxide generation compared with controls, and this was significantly inhibited by BEL. A modified iPLA(2) assay, Western blotting, and PCR confirmed that there was increased iPLA(2) activity and expression in neutrophils from people with diabetes. AA (10 mu M) partly rescued the inhibition of superoxide generation mediated by BEL, confirming that NADPH oxidase activity is, in part, regulated by AA. This study provides evidence for the role of iPLA(2) in enhanced superoxide generation in neutrophils from people with diabetes mellitus and presents an alternate pathway independent of protein kinase C and phosphatidic acid phosphohydrolase-1 hydrolase signaling. The Journal of Immunology, 2010, 184: 1507-1515.

DOI： 10.4049/jimmunol.0901219

Web of Science

PubMed

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

Resolvins are endogenous lipid mediators that actively regulate the resolution of acute inflammation. Resolvin E1 (RvE1; (5S, 12R, 18R)-trihydroxy-6Z, 8E, 10E, 14Z, 16E-eicosapentaenoic acid) is an endogenous anti-inflammatory and pro-resolving mediator derived from eicosapentaenoic acid that regulates leukocyte migration and enhances macrophage phagocytosis of apoptotic neutrophils to resolve inflammation. In the inflammatory milieu, RvE1 mediates counter-regulatory actions initiated via specific G protein-coupled receptors. Here, we have identified RvE1-specific signaling pathways initiated by the RvE1 receptor ChemR23. RvE1 stimulated phosphorylation of Akt that was both ligand-and receptor-dependent. RvE1 regulated Akt phosphorylation in a time (0-15 min)- and dose-dependent (0.01-100 nM) manner in human ChemR23-transfected Chinese hamster ovary cells. RvE1 stimulated phosphorylation of both Akt and a 30-kDa protein, a downstream target of Akt, identified using a phospho-Akt substrate antibody. The 30-kDa protein was identified as ribosomal protein S6, a translational regulator, and its phosphorylation was inhibited by a phosphatidylinositol 3-kinase (PI3K) inhibitor (wortmannin) and an ERK inhibitor (PD98059) but not by a p38-MAPK inhibitor (SB203580). Ribosomal protein S6 is a downstream target of the PI3K/Akt signaling pathway as well as the Raf/ERK pathway. In ChemR23-expressing differentiated HL60 cells, RvE1 also stimulated the phosphorylation of ribosomal protein S6. In addition, RvE1 enhanced phagocytosis of zymosanAby human macrophages, which are inhibited by PD98059 and rapamycin (mTOR inhibitor). These results indicate that RvE1 initiates direct activation of ChemR23 and signals receptor-dependent phosphorylation. These phosphorylation-signaling pathways identified for RvE1 receptor-ligand interactions underscore the importance of endogenous pro-resolving agonists in resolving acute inflammation.

DOI： 10.1074/jbc.M109.044131

Web of Science

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：SAGE PUBLICATIONS INC  

Phosphoinositide-dependent kinase (PDK1) plays a central role in signal transduction mediated by phosphatidylinositol 3-kinases (PI3K) and regulates cellular functions in neutrophils. Neutrophils from individuals diagnosed with localized aggressive periodontitis (LAP) present an in vivo phenotype with depressed chemotaxis. The aim of this study was to test the hypothesis that PDK1 regulates chemotaxis in neutrophils and is responsible for the abnormal neutrophil chemotaxis LAP. Neutrophil chemotaxis was significantly suppressed by the PDK1 inhibitor staurosporine. When cells were transfected with PDK1 siRNA, there was a significant reduction in chemotaxis, while superoxide generation was not significantly affected. In primary neutrophils from persons with LAP, PDK1 expression and activation levels were significantly reduced, and this reduction was associated with the reduced phosphorylation of Akt (Thr308) and chemotaxis. Analysis of these data demonstrates that PDK1 is essential for the chemotactic migration of neutrophils, and in the absence of PDK1, neutrophil chemotaxis is impaired.

DOI： 10.1177/0022034509349402

Web of Science

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：WILEY-BLACKWELL  

Background and purpose: The inflammation-resolving lipid mediator resolvin E1 (RvE1) effectively stops inflammation-induced bone loss in vivo in experimental periodontitis. It was of interest to determine whether RvE1 has direct actions on osteoclast (OC) development and bone resorption.
Experimental approach: Primary OC cultures derived from mouse bone marrow were treated with RvE1 and analysed for OC differentiation, cell survival and bone substrate resorption. Receptor binding was measured using radiolabelled RvE1. Nuclear factor (NF)-kappa B activation and Akt phosphorylation were determined with western blotting. Lipid mediator production was assessed with liquid chromatography tandem mass spectrometry.
Key results: OC growth and resorption pit formation were markedly decreased in the presence of RvE1. OC differentiation was inhibited by RvE1 as demonstrated by decreased number of multinuclear OC, a delay in the time course of OC development and attenuation of receptor activator of NF-kappa B ligand-induced nuclear translocation of the p50 subunit of NF-kappa B. OC survival and apoptosis were not altered by RvE1. Messenger RNA for both receptors of RvE1, ChemR23 and BLT(1) is expressed in OC cultures. Leukotriene B(4) (LTB(4)) competed with [(3)H] RvE1 binding on OC cell membrane preparations, and the LTB(4) antagonist U75302 prevented RvE1 inhibition of OC growth, indicating that BLT(1) mediates RvE1 actions on OC. Primary OC synthesized the RvE1 precursor 18R-hydroxy-eicosapentaenoic acid and LTB(4). Co-incubation of OC with peripheral blood neutrophils resulted in transcellular RvE1 biosynthesis.
Conclusions and implications: These results indicate that RvE1 inhibits OC growth and bone resorption by interfering with OC differentiation. The bone-sparing actions of RvE1 are in addition to inflammation resolution, a direct action in bone remodelling.

DOI： 10.1038/bjp.2008.367

Web of Science

researchmap

Authorship：Lead author   Language：English   Publishing type：Research paper (scientific journal)   Publisher：FEDERATION AMER SOC EXP BIOL  

Hyperglycemia associated with diabetes mellitus results in the priming of neutrophils leading to oxidative stress that is, in part, responsible for diabetic complications. p47phox, a NADPH oxidase cytosolic subunit, is a key protein in the assembly of the NADPH oxidase leading to superoxide generation. Little is known about the priming mechanism of oxidative pathways in neutrophils of people with diabetes. In this study, the kinetics of p47phox activation was investigated by comparing neutrophils from diabetic and healthy subjects, and the mechanism of hyperglycemia- induced changes was studied by using neutrophil- like HL- 60 cells as a model. In resting neutrophils from diabetic subjects, p47phox prematurely translocates to the cell membrane and preassembles with p22phox, a NADPH oxidase membrane subunit. This premature p47phox translocation and preassembly with p22phox were also observed in HL- 60 cells cultured with high glucose ( HG; 25 mM) and with the specific ligand for the receptor for advanced glycation end products ( RAGE), S100B. Phosphorylation of ERK1/ 2, but not p38 MAPK, was the primary signaling pathway, as evidenced by PD98059 suppressing the translocation of p47phox in HL- 60 cells incubated with HG and S100B. HL- 60 cells cultured in HG and S100B exhibited a 1.8- fold increase in fMLP- induced superoxide generation compared with those cultured in normal glucose ( 5.5 mM). These data suggest that HG and increased AGE prime neutrophils and increase oxidative stress inducing the translocation of p47phox to the cell membrane and preassembly with p22phox by stimulating a RAGE- ERK1/ 2 pathway.

DOI： 10.1189/jlb.1207832

Web of Science

researchmap

Authorship：Lead author   Language：English   Publishing type：Research paper (scientific journal)   Publisher：SPRINGER  

Cyclosporin A (CsA) is an immunosuppressant with severe side effects including gingival overgrowth. We have previously reported that CsA impairs the activity of the lysosomal enzymes cathepsin B and L in human gingival fibroblasts (HGFs). Here, we have examined the effects of CsA on the DNA-binding activity of the cyclic AMP response element-binding protein (CREB) and cell viability, and the effects of CREB on cathepsin B and L synthesis and activity in HGFs. We have confirmed that CsA down-regulates cathepsin B and L synthesis. Further, CsA has no effect on cell viability and dramatically impairs CREB-DNA binding activity. Importantly, the synthesis of cathepsin B and L is down-regulated, and their activity is also significantly impaired in HGFs transfected with plasmid expressing dominant-negative CREB. These results suggest that CREB is essential for the CsA-mediated down-regulation of cathepsin B and L synthesis in HGFs.

DOI： 10.1007/s00441-007-0457-8

Web of Science

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：BLACKWELL MUNKSGAARD  

Background: Gingival overgrowth is a common side-effect following administration of cyclosporin A. We reported previously that lysosomal protease cathepsin-L activity, but not cathepsin-B, was significantly suppressed by short-term cyclosporin A exposure in human gingival fibroblasts. Although this suppression may lead to decreased degradation of gingival connective tissue, a net increase in matrix proteins, and gingival overgrowth, the effects of cyclosporin A need to be more elucidated, considering the long-term use for patients following organ transplantation.
Objective: The aim of the present study was to evaluate the effects of clinically relevant doses of cyclosporin A on cultured human gingival fibroblasts. We evaluated the effects of long-term cyclosporin A exposure on cell proliferation, mRNA expression of various proteases and both cathepsin-B and -L activity in human gingival fibroblasts.
Materials and Methods: Human gingival fibroblasts were isolated from three donors' healthy gingiva and cultured from five to eight passages with or without 200 ng/ml of cyclosporin A. Proliferative activity of cyclosporin A-treated cells was examined using MTT assay. Total RNA and cellular proteins were collected for semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis and for measurement of the cathepsin-B and -L activity.
Results: Long-term cyclosporin A exposure had no effects on cell proliferation. Accumulation of cathepsin-B, -H and -L mRNA was markedly suppressed by long-term cyclosporin A exposure, whereas accumulation of another lysosomal enzyme N-acetyl-beta-d-glucosaminidase mRNA, which is involved in remodeling of gingival epithelium, was not apparently impaired in cyclosporin A-treated cells. Accumulation of matrix metalloprotease-1 (MMP-1) and tissue inhibitor of matrix metalloprotease-1 (TIMP-1) mRNA, which are involved in remodeling of extracellular matrix, also was not impaired. In addition, we demonstrated that long-term cyclosporin A exposure significantly suppressed not only the activity of the active form of cathepsin-(B + L) compared to the activity in non-treated cells (p = 0.0458), but also the activity of the active form of cathepsin-B (p &lt; 0.0001) in human gingival fibroblasts.
Conclusion: The decreased ability of protein degradation by not only cathepsin-L but also cathepsin-B is, at least, one of the several factors developing the cyclosporin A-induced gingival overgrowth.

DOI： 10.1111/j.1600-0765.2004.00746.x

Web of Science

researchmap

Authorship：Lead author   Language：English   Publishing type：Research paper (scientific journal)   Publisher：AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC  

Diabetic patients are susceptible to severe inflammatory periodontitis manifesting as swollen gingiva with bleeding, but the underlying mechanism is not well understood. Our purpose was to determine the effect of a high glucose (HG) condition on the interleukin-6/soluble interleukin-6 receptor (IL-6/sIL-6R)-induced activation of signaling and vascular endothelial growth factor (VEGF) expression in human gingival fibroblasts (HGFs). In this study, HGFs were cultured for at least two passages under a normal glucose (NG; 5.5 mm) condition or high glucose (25 mm) condition. Importantly, the HG condition significantly induced expression of gp130 mRNA in HGFs compared with levels in control cells. Consistent with the expression of its mRNA, the HG condition also increased the expression of gp130 protein, and phosphorylation of the tyrosine residue by gp130 was enhanced significantly by IL-6/sIL-6R stimulation. Furthermore, the HG condition enhanced the IL-6/sIL-6R-induced phosphorylation of p44/42 MAPK and led to subsequent activation of CCAAT/enhancer binding protein in nuclei. In contrast, there was no significant difference in phosphorylation of JNK between the HG and NG condition. Interestingly, HGFs increased IL-6/sIL-6R,induced VEGF165 mRNA expression and VEGF165 secretion under the HG condition compared with levels under the NG condition. In contrast, the induction of VEGF165 secretion was partially inhibited by PD98059 (selective p44/42 MAPK inhibitor) under the HG condition. In addition, the VEGF165 secretion was completely inhibited by the combination of PD98059 and SP600125 (JNK inhibitor). Our findings suggest that the HG condition indirectly increases VEGF expression via activation of gp130-mediated p44/42 MAPK-CCAAT/enhancer binding protein signaling in HGFs. Thus, elevated VEGF secretion in HGFs under the HG condition may play a role in the development of the severe periodontitis observed in diabetic patients.

DOI： 10.1074/jbc.M311688200

Web of Science

researchmap

Language：English   Publishing type：Research paper (scientific journal)   Publisher：LIPPINCOTT WILLIAMS & WILKINS  

Angiogenesis is a common complication of organtransplant rejection. One of the primary responsible molecules for enhanced angiogenesis is vascular endothelial growth factor (VEGF). Activated protein (AP)-1 is considered to play a key role in the transcription of VEGF. c-jun N-terminal kinase (JNK), one of the MAP kinase family members, plays a critical role in AP-1 activation. Thus, we tested the effect of a novel JNK inhibitor, SP600125, on VEGF production in fibroblasts. SP600125 significantly suppressed interleukin (IL)-6-induced production of VEGF in cultured fibroblasts. Cyclosporine A (CsA), a known in vitro antiangiogenic reagent, partially mimicked this suppression. In fact, CsA suppressed IL-6-induced phosphorylation of JNK. The results indicate that although both SP600125 and CsA are anti-angiogenic by inhibiting VEGF production by way of a JNK-dependent pathway, the inhibitory effect was much stronger with the novel inhibitor of JNK than with CsA.

DOI： 10.1097/01.TP.0000085661.52980.95

Web of Science

researchmap

researchmap

researchmap

researchmap

researchmap

researchmap

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：English   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

J-GLOBAL

researchmap

Language：Japanese   Publisher：(一社)日本心臓病学会  

researchmap

Language：Japanese   Publisher：(一社)日本糖尿病合併症学会  

researchmap

Language：Japanese   Publisher：(一社)日本糖尿病合併症学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

Language：Japanese   Publisher：岡山歯学会  

researchmap

Language：Japanese   Publisher：岡山歯学会  

researchmap

Language：Japanese   Publisher：(一社)日本口腔検査学会  

researchmap

Language：Japanese   Publisher：(一社)日本未病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：日本成人先天性心疾患学会  

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

Language：Japanese   Publisher：岡山歯学会  

researchmap

Language：Japanese   Publisher：岡山歯学会  

researchmap

Language：Japanese   Publisher：岡山歯学会  

researchmap

Language：Japanese   Publisher：(一社)日本未病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(株)診断と治療社  

歯周病は、Porphyromonas gingivalisに代表される歯周病原細菌が歯周組織に感染して発症する口腔感染症である。近年、歯周病原細菌の感染、そして、感染によって惹起された歯周炎症が不妊環境の構築に関与する可能性が示唆されはじめている。本稿では、歯周病と不妊の関連について文献的に考察するとともに、不妊治療中の重度歯周病患者に専門的治療を行うことによって自然妊娠・正常出産に至った実症例を提示しながら、その関連性を考察する。(著者抄録)

researchmap

Other Link： https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2021&ichushi_jid=J00525&link_issn=&doc_id=20210324150010&doc_link_id=%2Fae4sanke%2F2021%2F008804%2F011%2F0465b0469%26dl%3D3&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fae4sanke%2F2021%2F008804%2F011%2F0465b0469%26dl%3D3&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_4.gif

J-GLOBAL

researchmap

Language：Japanese   Publisher：岡山歯学会  

researchmap

Language：Japanese   Publisher：岡山歯学会  

researchmap

Language：Japanese   Publisher：岡山歯学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：岡山歯学会  

researchmap

Language：Japanese   Publisher：(一社)日本有病者歯科医療学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(一社)日本歯科薬物療法学会  

researchmap

Language：Japanese   Publisher：(株)ヒョーロン・パブリッシャーズ  

researchmap

Language：English   Publisher：日本成人先天性心疾患学会  

researchmap

J-GLOBAL

researchmap

Language：Japanese   Publisher：岡山歯学会  

researchmap

Language：Japanese   Publisher：岡山歯学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(一社)日本未病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(一社)日本未病システム学会  

researchmap

Language：Japanese   Publisher：(一社)日本糖尿病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：日本口腔機能水学会  

researchmap

Language：Japanese   Publisher：(株)ヒョーロン・パブリッシャーズ  

researchmap

Language：Japanese   Publisher：(株)ヒョーロン・パブリッシャーズ  

researchmap

Language：English   Publisher：日本成人先天性心疾患学会  

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：日本歯科衛生学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(株)ヒョーロン・パブリッシャーズ  

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(公社)日本歯科医師会  

researchmap

Language：Japanese   Publisher：(公社)日本歯科医師会  

researchmap

Language：Japanese   Publisher：(公社)日本歯科医師会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(株)医学書院  

researchmap

Language：Japanese   Publisher：(一社)日本糖尿病合併症学会  

researchmap

J-GLOBAL

researchmap

J-GLOBAL

researchmap

Language：Japanese   Publisher：岡山歯学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(一社)日本糖尿病合併症学会  

researchmap

Language：Japanese   Publisher：(株)メディカルレビュー社  

「歯周病セルフチェック票(以下セ票)」の妥当性を検討する目的で、2型糖尿病患者156名を対象に、セ票(全11項目、計21点)に記入後、歯科検診を実施した。検診評価項目として残存歯数、プラークスコア、歯肉炎指数、歯周ポケット深さを用いた。合計点数4点以下(罹患の可能性小)が32名、5〜9点(罹患の可能性大)が66名、10点以上(重度罹患の可能性大)が58名で、歯周ポケットの最大深度および全歯周ポケットに対する4mm以上の歯周ポケット深さが占める割合は、10点以上の群で他の2群より有意に高値を示した。セ票10点以上は、糖尿病患者における歯周病スクリーニングに有用であると考えられた。(著者抄録)

researchmap

Language：Japanese   Publisher：日本歯科衛生学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

J-GLOBAL

researchmap

Language：Japanese   Publisher：岡山歯学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：ヒョーロン・パブリッシャーズ  

CiNii Article

CiNii Books

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

DOI： 10.2329/perio.55.9

researchmap

Other Link： https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2013&ichushi_jid=J01095&link_issn=&doc_id=20130424430002&doc_link_id=%2Fcp9perlo%2F2013%2F005501%2F003%2F0009-0014%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fcp9perlo%2F2013%2F005501%2F003%2F0009-0014%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

Language：Japanese   Publisher：(一社)日本糖尿病合併症学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(株)デンタルダイヤモンド社  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

researchmap

Language：Japanese   Publisher：(一社)日本糖尿病合併症学会  

researchmap

Language：Japanese   Publisher：岡山歯学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯周病学会  

researchmap

Language：Japanese   Publisher：(NPO)日本歯科保存学会  

researchmap

Language：Japanese  

CiNii Article

researchmap

Language：Japanese  

CiNii Article

researchmap

Language：Japanese  

CiNii Article

researchmap

Language：Japanese   Publisher：The Japanese Society of Periodontology  

CiNii Article

CiNii Books

researchmap

Event date： 2020.12

Language：Japanese  

researchmap

Event date： 2020.11

Language：Japanese  

researchmap

Event date： 2020.6

Language：Japanese  

researchmap

Event date： 2020.5

Language：Japanese  

researchmap

Event date： 2020.5

Language：Japanese  

researchmap

Event date： 2019.12

Language：Japanese  

researchmap

Event date： 2019.12

Language：Japanese  

researchmap

Event date： 2019.10

Language：Japanese  

researchmap

Event date： 2019.5

Language：Japanese  

researchmap

Event date： 2019.5

Language：Japanese  

researchmap

Event date： 2019.5

Language：Japanese  

researchmap

Event date： 2019.5

Language：Japanese  

researchmap

Event date： 2019.3

Language：Japanese  

researchmap

Event date： 2019.1

Language：English  

researchmap

Event date： 2018.12

Language：Japanese  

researchmap

Event date： 2018.12

Language：Japanese  

researchmap

Event date： 2018.10

Language：Japanese  

researchmap

Event date： 2018.10

Language：Japanese  

researchmap

Event date： 2018.10

Language：Japanese  

researchmap

Event date： 2018.10

Language：Japanese  

researchmap

Event date： 2018.10

Language：Japanese  

researchmap

Event date： 2018.5

Language：Japanese  

researchmap

Event date： 2018.5

Language：Japanese  

researchmap

Event date： 2018.5

Language：Japanese  

researchmap

Event date： 2018.5

Language：Japanese  

researchmap

Event date： 2018.5

Language：Japanese  

researchmap

Event date： 2018.3

Language：Japanese  

researchmap

Event date： 2017.11

Language：Japanese  

researchmap

Event date： 2017.11

Language：Japanese  

researchmap

Event date： 2017.11

Language：Japanese  

researchmap

Event date： 2017.11

Language：Japanese  

researchmap

Event date： 2017.11

Language：Japanese  

researchmap

Event date： 2017.10

Language：Japanese  

researchmap

Event date： 2017.10

Language：Japanese  

researchmap

Event date： 2017.8

Language：Japanese  

researchmap

Event date： 2017.5

Language：Japanese  

researchmap

Event date： 2017.5

Language：Japanese  

researchmap

Event date： 2017.5

Language：Japanese  

researchmap

Event date： 2017.4

Language：Japanese  

researchmap

Event date： 2017.4

Language：Japanese  

researchmap

Event date： 2017.4

Language：Japanese  

researchmap

Event date： 2017.4

Language：Japanese  

researchmap

Event date： 2017.4

Language：Japanese  

researchmap

Event date： 2016.10

Language：Japanese  

researchmap

Event date： 2016.9

Language：Japanese  

researchmap

Event date： 2016.9

Language：Japanese  

researchmap

Event date： 2016.9

Language：Japanese  

researchmap

Event date： 2016.8

Language：Japanese  

researchmap

Event date： 2016.8

Language：Japanese  

researchmap

Event date： 2016.8

Language：Japanese  

researchmap

Event date： 2016.6

Language：Japanese  

researchmap

Event date： 2016.6

Language：Japanese  

researchmap

Event date： 2016.4

Language：Japanese  

researchmap

Event date： 2016.4

Language：Japanese  

researchmap

Event date： 2016.4

Language：Japanese  

researchmap

Event date： 2016.4

Language：Japanese  

researchmap

Event date： 2015.12

Language：Japanese  

researchmap

Event date： 2015.11

Language：Japanese  

researchmap

Event date： 2015.11

Language：Japanese  

researchmap

Event date： 2015.8

Language：Japanese  

researchmap

Event date： 2015.8

Language：Japanese  

researchmap

Event date： 2015.8

Language：Japanese  

researchmap

Event date： 2015.8

Language：Japanese  

researchmap

Event date： 2015.6

Language：Japanese  

researchmap

Event date： 2015.4

Language：Japanese  

researchmap

Event date： 2015.4

Language：Japanese  

researchmap

Event date： 2014.12

Language：Japanese  

researchmap

Event date： 2014.10

Language：Japanese  

researchmap

Event date： 2014.9

Language：Japanese  

researchmap

Event date： 2014.4

Language：Japanese  

researchmap

Event date： 2013.4

Language：Japanese  

researchmap

Event date： 2013.4

Language：Japanese  

researchmap

Event date： 2012.10

Language：Japanese  

researchmap

Event date： 2012.10

Language：Japanese  

researchmap

Event date： 2012.9

Language：Japanese  

researchmap

Event date： 2012.5

Language：Japanese  

researchmap

Event date： 2012.4

Language：Japanese  

researchmap

Event date： 2011.9

Language：Japanese  

researchmap

Event date： 2011.5

Language：Japanese  

researchmap

Event date： 2011.4

Language：Japanese  

researchmap

Event date： 2010.10

Language：Japanese  

researchmap

Event date： 2010.9

Language：Japanese  

researchmap

Event date： 2010.5

Language：Japanese  

researchmap

Event date： 2009.9

Language：Japanese  

researchmap

Event date： 2009.6

Language：Japanese  

researchmap

Event date： 2009.5

Language：Japanese  

researchmap

Event date： 2009.4

Language：Japanese  

researchmap

Event date： 2008.10

Language：Japanese  

researchmap

Event date： 2003.9.25

Language：Japanese  

researchmap

Event date： 2003.9.25

Language：Japanese  

researchmap

Event date： 2002.10.21

Language：Japanese  

researchmap

Event date： 2001.9.30

Language：Japanese  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Symposium, workshop panel (nominated)  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Symposium, workshop panel (nominated)  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Media coverage  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Poster presentation  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Oral presentation (general)  

researchmap

Presentation type：Public lecture, seminar, tutorial, course, or other speech  

researchmap

Presentation type：Oral presentation (general)  

researchmap

researchmap

researchmap

researchmap

researchmap

Presentation type：Poster presentation  

researchmap

researchmap

researchmap

researchmap

researchmap

researchmap

researchmap

researchmap